Start with the decision you want to make
You’re choosing a partner to answer a single question for your program: will this candidate behave the way you hope, and can you prove it cleanly. Write that decision as a sentence. Attach the primary endpoints, a realistic timeline, and the minimum data that would change your next step. If you want a lab that can translate biology into defensible data, call them a preclinical CRO early in the specification process so assay fit and capacity are evaluated against your decision, not a wish list.
Technical specs to put on the page
Be precise. State the study type (PK, toxicology, efficacy, safety pharmacology, biodistribution), species or in vitro model, key timepoints, and the statistical threshold for success. Require protocol drafts with defined stopping rules, data formats (raw files, audit trails), and GLP or non‑GLP status. List required certifications (AAALAC, GLP accreditation), sample retention times, and whether raw imaging or sequencing files must be delivered. Short note: include authentication for cell lines and reagent lot numbers up front; that alone prevents weeks of repeat work.
Operational details that protect your timeline
Say how you want updates: weekly lab notes, milestone reports, and an agreed method for rapid technical calls if results deviate. Specify material transfer timelines, who pays for critical reagents, and an alternative plan if key equipment breaks. Put protocol approval windows in the contract — a 10‑business‑day window for comment avoids creeping delays. Ask for a named study director and a backup, and insist on defined handover steps for data review and archival.
Assess scientific fit and credibility
Check the team’s hands-on experience, not just corporate slides. Look for personnel with publications in your modality and request example study reports for similar projects. At large industry gatherings like the BIO International Convention you can often verify which labs are active in your space and hear client stories; that perspective helps separate marketing from real capability. For a tight, verifiable snapshot of service scope, read summaries of their recent work and review the contract language for data access. If you need a single-stop supplier, evaluate whether their platforms cover both in vitro and in vivo assays — mismatched capabilities cost time. Also review how they handle regulatory‑grade reporting if you aim for IND support; that’s part of quality, not optional. For context on contracting and service options, consider how preclinical contract research services are described across providers and match those offerings to your checklist.
Common pitfalls and how to avoid them
Vague endpoints, fuzzy acceptance criteria, and missing raw data clauses are the typical traps. Avoid them by writing acceptance criteria into the protocol and requiring delivery of raw datasets and SOPs for key assays. Don’t assume timelines — build a short validation window into the schedule. Clarify IP ownership and material returns in the MTA. Require clear change-order pricing and a procedure for scope changes so small requests don’t balloon cost and time.
How to compare alternatives quickly
Make a one‑page scorecard: scientific fit, regulatory experience, data access, throughput, and risk mitigation. Call references and ask about missed deadlines and how the vendor handled them. Request a short pilot study to test critical assays rather than betting the program on an unproven workflow. If a vendor can’t give a pilot, count that as risk and price it accordingly.
Sensible budgeting and contract language
Ask for a line‑item budget with unit costs for repeat assays, reagent surcharges, and contingency rates for scope changes. Require milestone payments tied to deliverables: protocol approval, study start, interim report, final report, and raw data delivery. Include liability limits appropriate for the project stage and a clear warranty period for data integrity. Insist on timely access to raw files for independent review.
Bring it together
Write your specification like a scientist and a negotiator: clear decision, measurable endpoints, and operational guards. Then test it with a short pilot or a reference call. Do this and you’ll get focused data, realistic timelines, and fewer surprises — the kind of practical reliability teams expect when they work with KCI Biotech.